首页> 外国专利> Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties

Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties

机译:一氧化氮释放的羟吲哚前药具有止痛和抗炎作用

摘要

Nitric oxide releasing oxindole prodrugs are described which are useful in methods of treating or preventing pain, inflammation, fever, or gastrointestinal lesions in a patient in need of such treatment, or of modifying an inflammatory disease or condition by favorably affecting the outcome thereof in said patient, wherein there is administered to said patient a therapeutically effective amount of a compound of Formula (I); and pharmaceutically acceptable salts thereof: whereinX is a covalent bond, -O-, -S-, or -N(R1)-;RA and RB are members independently selected from the group consisting essentially of H; (C1-C4)alkyl; (C3-C6)cycloalkyl; phenyl; or taken together with the carbon atom to which they are attached, form a bridging (C3-C6)cycloalkyl moiety;n is an integer selected from 1 through 6, inclusive;Y is a covalent bond -O-, -S-, or -N-;Z is -NO or -NO2;RC is a member independently selected from the group consisting essentially of H, F, Cl, Br, (C1-C4)alkyl, (C3-C7)cycloalkyl, (C1-C4)alkoxy, (C1-C4)alkylthio, CF3, (C1-C4)alkylsulfinyl, (C1-C4)alkylsulfonyl, NO2, phenyl, (C2-C4)alkanoyl, benzoyl, thenoyl, (C2-C4)alkanamido, benzamido, and N,N-di-(C1-C3)alkylsulfamoyl;RD is a member independently selected from the group consisting essentially of H, F, Cl, Br, (C1-C4)alkyl, (C3-C7)cycloalkyl, (C1-C4)alkoxy, (C1-C4)alkylthio, and CF3; orRC and RD when taken together are a methylenedioxy group or an ethylenedioxy group; or form a divalent radical D, wherein D is selected from the group consisting essentially of wherein W is O or S;RE is a member independently selected from the group consisting essentially of (C1-C6)alkyl, (C3-C7)cycloalkyl, (C4-C7)cycloalkenyl, phenyl, phenyl(C1-C3)alkyl, phenoxy(C1-C3)alkyl, thiophenoxy(C1-C3)alkyl, naphtyl, bicyclo[2.2.1]heptan-2-yl, bicyclo[2.2.1]hept-5-en-2-yl, and -(CH2)m-Q-R2;R7 and R9 are independently selected from the group consisting essentially of hydrogen, (C1-C3)alkyl, -C(=O)(C1-C3)alkyl, phenyl, and -C(=O)N(R8)(R10).
机译:描述了释放一氧化氮的羟吲哚前药,其可用于在需要这种治疗的患者中治疗或预防疼痛,炎症,发烧或胃肠道损伤的方法,或通过有利地影响其结果来改善炎性疾病或病症的方法。患者,其中向该患者施用治疗有效量的式(I)化合物; <图像文件=“ 80000001.GIF” he =“ 43” imgContent =“ chem” imgFormat =“ GIF” inline =“ no “ orientation =“ portrait” wi =“ 102” />及其药学上可接受的盐:其中 X是共价键,-O-,-S-或-N(R1)-; RA和RB是独立地选自基本上由H组成的组的成员; (C1-C4)烷基; (C3-C6)环烷基;苯基或与它们所连接的碳原子一起形成一个桥接(C3-C6)环烷基部分; n是一个1到6之间的整数,包括1和6; Y是共价键-O-,-S-或-N-; Z是-NO或-NO2; RC是独立地选自以下组成的组的成员基本上由H,F,Cl,Br,(C1-C4)烷基,(C3-C7)环烷基,(C1-C4)烷氧基,(C1-C4)烷硫基,CF3,(C1-C4)烷基亚磺酰基,(C1- C4)烷基磺酰基,NO2,苯基,(C2-C4)烷酰基,苯甲酰基,壬酰基,(C2-C4)烷酰胺基,苯甲酰胺和N,N-二-(C1-C3)烷基氨磺酰基; RD R 1是独立地选自H,F,Cl,Br,(C 1 -C 4)烷基,(C 3 -C 7)环烷基,(C 1 -C 4)烷氧基,(C 1 -C 4)烷硫基和CF 3的成员;或 RC和RD一起为亚甲二氧基或亚乙二氧基;或或形成二价基团D,其中D基本上选自其中W是O或S的基团; RE是独立地选自基本上由(C1-C6)烷基组成的组的成员, (C3-C7)环烷基,(C4-C7)环烯基,苯基,苯基(C1-C3)烷基,苯氧基(C1-C3)烷基,噻吩氧基(C1-C3)烷基,萘基,双环[2.2.1]庚基- 2-基,双环[2.2.1]庚-5-基-2-基和-(CH2)mQ-R2; R7和R9独立地选自基本上由氢组成的组, (C1-C3)烷基,-C(= O)(C1-C3)烷基,苯基和-C(= O)N(R8)(R10)。

著录项

  • 公开/公告号EP0984012A3

    专利类型

  • 公开/公告日2001-01-10

    原文格式PDF

  • 申请/专利权人 PFIZER PRODUCTS INC.;

    申请/专利号EP19990306575

  • 发明设计人 LUNDY KRISTIN MARIE;CLARK MICHAEL THOMAS;

    申请日1999-08-19

  • 分类号C07D409/06;C07D405/06;C07D209/34;A61K31/40;A61P29/00;

  • 国家 EP

  • 入库时间 2022-08-22 01:16:31

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号